Gene · 837
Papers3,388
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,388
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies. | Acta Pharm Sin B | 2023 | 36815034 | PubTator, text mining | PubMed |
| Reconstitution of human pyroptotic cell death in Saccharomyces cerevisiae. | Sci Rep | 2023 | 36813876 | PubTator, text mining | PubMed |
| Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus. | Nat Commun | 2023 | 36797275 | PubTator, text mining | PubMed |
| Knockout of AMD-associated gene POLDIP2 reduces mitochondrial superoxide in human retinal pigment epithelial cells. | Aging (Albany NY) | 2023 | 36795578 | PubTator, text mining | PubMed |
| [Associations of genetic variations in pyroptosis related genes with acute adverse events in postoperative rectal cancer patients receiving concurrent chemoradiotherapy]. | Zhonghua Zhong Liu Za Zhi | 2023 | 36781235 | PubTator, text mining | PubMed |
| Pyroptosis as a double-edged sword: The pathogenic and therapeutic roles in inflammatory diseases and cancers. | Life Sci | 2023 | 36780939 | PubTator, text mining | PubMed |
| HIV-1 release requires Nef-induced caspase activation. | PLoS One | 2023 | 36780482 | PubTator, text mining | PubMed |
| Caspase-11 promotes high-fat diet-induced NAFLD by increasing glycolysis, OXPHOS, and pyroptosis in macrophages. | Front Immunol | 2023 | 36776889 | PubTator, text mining | PubMed |
| Caspase-11 contributes to site-1 protease cleavage and SREBP1 activation in the inflammatory response of macrophages. | Front Immunol | 2023 | 36776855 | PubTator, text mining | PubMed |
| From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children. | Int J Mol Sci | 2023 | 36769320 | PubTator, text mining | PubMed |
| The Potential Role of Connexins in the Pathogenesis of Atherosclerosis. | Int J Mol Sci | 2023 | 36768920 | PubTator, text mining | PubMed |
| Understanding Interstitial Lung Diseases Associated with Connective Tissue Disease (CTD-ILD): Genetics, Cellular Pathophysiology, and Biologic Drivers. | Int J Mol Sci | 2023 | 36768729 | PubTator, text mining | PubMed |
| miRNA Molecules-Late Breaking Treatment for Inflammatory Bowel Diseases? | Int J Mol Sci | 2023 | 36768556 | PubTator, text mining | PubMed |
| Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases. | Int J Mol Sci | 2023 | 36768323 | PubTator, text mining | PubMed |
| CASP4/11 Contributes to NLRP3 Activation and COVID-19 Exacerbation. | J Infect Dis | 2023 | 36763010 | PubTator, text mining | PubMed |
| Immunity against Moraxella catarrhalis requires guanylate-binding proteins and caspase-11-NLRP3 inflammasomes. | EMBO J | 2023 | 36762431 | PubTator, text mining | PubMed |
| Gallic acid ameliorates dextran sulfate sodium-induced ulcerative colitis in mice via inhibiting NLRP3 inflammasome. | Front Pharmacol | 2023 | 36762118 | PubTator, text mining | PubMed |
| Transcriptome analysis of a newly established mouse model of Toxoplasma gondii pneumonia. | Parasit Vectors | 2023 | 36755348 | PubTator, text mining | PubMed |
| Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. | J Immunother Cancer | 2023 | 36754451 | PubTator, text mining | PubMed |
| The Dengue virus protease NS2B3 cleaves cyclic GMP-AMP synthase to suppress cGAS activation. | J Biol Chem | 2023 | 36754281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/837/papers?page=26